Zobrazeno 1 - 10
of 1 204
pro vyhledávání: '"HARENBERG J"'
Autor:
Marchetti, M., Gomez Rosas, P., Ambaglio, C., Sanga, E., Barcella, L., Schieppati, F., Harenberg, J., Falanga, A.
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
Autor:
Loffredo L., Vidili G., Sciacqua A., Cogliati C., Di Giulio R., Bernardini S., Ciacci P., Pietrangelo A., Orlando F., Paraninfi A., Boddi M., Di Minno G., Falsetti L., Lodigiani C., Santoliquido A., Ettorre E., Pignatelli P., Arezzo M. F., Gutu E., Harenberg J., Violi F., Casciaro M. A., Morelli S., Accapezzato D., Rossi E., Palumbo I. M., Pannunzio A., Fallarino A., Maggio E., Bocchini V. P., Gioia C., Izzo R., Luongo R., Cosenza M., Bisciglia M. F., Battaglia S., Pirillo L. S., Capozza A., Summa M. L., Armentaro G., Volpentesta M., Rullo R., Baldinia L., Arienti V., Meloni P. L., Sauchella A., Melis S., Berria M., Solinas B., Vilardi L., Sarobba P., Pisanu M., Mangatia P., Cringoli M., Blanca D., Casella F., Vegetti A., Crociani A., Donnarumma E., Pacciani G., Rovereto R., Lunardi S., Tufano A., Pacetti V., Domenicali M., Leopoldo P., Ceci F.
Background Acutely ill medical patients experience deep venous thrombosis (DVT) during the hospitalization, however the time course of DVT is still unclear. Objectives To evaluate risk factors in acutely ill hospitalized medical patients for proximal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21cd953c0d3fa05c88c5c07dace770c0
https://hdl.handle.net/11573/1681130
https://hdl.handle.net/11573/1681130
Autor:
Gerotziafas G. T., Catalano M., Colgan M. -P., Pecsvarady Z., Wautrecht J. C., Fazeli B., Olinic D. -M., Farkas K., Elalamy I., Falanga A., Fareed J., Papageorgiou C., Arellano R. S., Agathagelou P., Antic D., Auad L., Banfic L., Bartolomew J. R., Benczur B., Bernardo M. B., Boccardo F., Cifkova R., Cosmi B., De Marchi S., Dimakakos E., Dimopoulos M. A., Dimitrov G., Durand-Zaleski I., Edmonds M., El Nazar E. A., Erer D., Esponda O. L., Gresele P., Gschwandtner M., Gu Y., Heinzmann M., Hamburg N. M., Hamade A., Jatoi N. -A., Karahan O., Karetova D., Karplus T., Klein-Weigel P., Kolossvary E., Kozak M., Lefkou E., Lessiani G., Liew A., Marcoccia A., Marshang P., Marakomichelakis G., Matuska J., Moraglia L., Pillon S., Poredos P., Prior M., Salvador D. R. K., Schlager O., Schernthaner G., Sieron A., Spaak J., Spyropoulos A., Sprynger M., Suput D., Stanek A., Stvrtinova V., Szuba A., Tafur A., Vandreden P., Vardas P. E., Vasic D., Vikkula M., Wennberg P., Zhai Z., Bikdeli B., Guo Y., Harenberg J., Hu Y., Lip G. Y. H., Roldan V.
Publikováno v:
Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2020, 120 (12), pp.1597-1628. ⟨10.1055/s-0040-1715798⟩
Thrombosis and haemostasis, Vol. 120, no. 12, p. 1597-1628 (2020)
Thrombosis and Haemostasis, Schattauer, 2020, 120 (12), pp.1597-1628. ⟨10.1055/s-0040-1715798⟩
Thrombosis and haemostasis, Vol. 120, no. 12, p. 1597-1628 (2020)
COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing risk factors to severe COVID-19 are male sex, underlying cardiovascular d
Publikováno v:
In Journal of Thrombosis and Haemostasis July 2012 10(7):1433-1436
Autor:
HARENBERG, J. *, KAKKAR, A., BERGQVIST, D., BARROWCLIFFE, T., CASU, B., FAREED, J., MISMETTI, P., OFOSU, F.A., RAAKE, W., SAMAMA, M., SCHULMAN, S.
Publikováno v:
In Journal of Thrombosis and Haemostasis July 2009 7(7):1222-1225
Autor:
Harenberg, J.
Publikováno v:
In Thrombosis Research 2009 123 Supplement 3:S1-S4
Autor:
Harenberg, J., Gosselin, R., Pabinger, I., Becattini, C., Cuker, A., Hetjens, S., Weiss, C., Klamroth, R., Herkner, H., Langer, F.
Publikováno v:
Hämostaseologie; 2024 Supplement 1, Vol. 44, pS106-S107, 2p
Autor:
Vassart, J., Boucher, A.-Y., Morimont, L., Tafur, A., Walenga, J., Harenberg, J., Douxfils, J.
Publikováno v:
Hämostaseologie; 2024 Supplement 1, Vol. 44, pS95-S96, 2p
COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation, microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing risk factors to severe COVID-19 are male sex, underlying cardiovascular d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::66e9760e2bb953ec80ccb8929968f83c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103516
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103516